[1] |
FAID A H, SHOUMAN S A, BADR Y A, et al. Enhanced cytotoxic effect of doxorubicin conjugated gold nanoparticles on breast cancer model[J]. BMC Chem, 2022, 16(1):90. doi: 10.1186/s13065-022-00889-9 |
[2] |
SHAFEI A, EL-BAKLY W, SOBHY A, et al. A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer[J]. Biomedecine Pharmacother, 2017, 95:1209-1218. doi: 10.1016/j.biopha.2017.09.059 |
[3] |
YANG S, SHIM M K, KIM W J, et al. Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity[J]. Biomaterials, 2021, 272:120791. doi: 10.1016/j.biomaterials.2021.120791 |
[4] |
CARVALHO C, SANTOS R X, CARDOSO S, et al. Doxorubicin: the good, the bad and the ugly effect[J]. Curr Med Chem, 2009, 16(25):3267-3285. doi: 10.2174/092986709788803312 |
[5] |
MEREDITH A M, DASS C R. Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism[J]. J Pharm Pharmacol, 2016, 68(6):729-741. doi: 10.1111/jphp.12539 |
[6] |
PUGAZHENDHI A, EDISON T N J I, VELMURUGAN B K, et al. Toxicity of Doxorubicin (Dox) to different experimental organ systems[J]. Life Sci, 2018, 200:26-30. doi: 10.1016/j.lfs.2018.03.023 |
[7] |
LUAN S Y, XIE R, YANG Y S, et al. Acid-responsive aggregated gold nanoparticles for radiosensitization and synergistic chemoradiotherapy in the treatment of esophageal cancer[J]. Small, 2022, 18(19):e2200115. doi: 10.1002/smll.202200115 |
[8] |
李廷廷, 张娜. 纳米金的表面修饰及其在抗肿瘤中的应用[J]. 药物生物技术, 2015, 22(2):160-164. |
[9] |
KIM H S, YOON S, SON Y J, et al. High-yield clicking and dissociation of doxorubicin nanoclusters exhibiting differential cellular uptakes and imaging[J]. J Control Release, 2015, 217:64-73. doi: 10.1016/j.jconrel.2015.08.037 |
[10] |
胡瑞省, 刘善堂, 朱涛, 等. 金纳米粒子通过形成Au-S键的组装[J]. 物理化学学报, 1999, 15(11):961-965. |
[11] |
RUAN S B, YUAN M Q, ZHANG L, et al. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles[J]. Biomaterials, 2015, 37:425-435. doi: 10.1016/j.biomaterials.2014.10.007 |
[12] |
SUN G Y, DU Y C, CUI Y X, et al. Terminal deoxynucleotidyl transferase-catalyzed preparation of pH-responsive DNA nanocarriers for tumor-targeted drug delivery and therapy[J]. ACS Appl Mater Interfaces, 2019, 11(16):14684-14692. doi: 10.1021/acsami.9b05358 |
[13] |
CUN X L, CHEN J T, RUAN S B, et al. A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration[J]. ACS Appl Mater Interfaces, 2015, 7(49):27458-27466. doi: 10.1021/acsami.5b09391 |
[14] |
SUARASAN S, CRACIUN A M, LICARETE E, et al. Intracellular dynamic disentangling of doxorubicin release from luminescent nanogold carriers by fluorescence lifetime imaging microscopy (FLIM) under two-photon excitation[J]. ACS Appl Mater Interfaces, 2019, 11(8):7812-7822. doi: 10.1021/acsami.8b21269 |
[15] |
ZHANG Z M, GAO P C, WANG Z F, et al. DNA-caged gold nanoparticles for controlled release of doxorubicin triggered by a DNA enzyme and pH[J]. Chem Commun, 2015, 51(65):12996-12999. doi: 10.1039/C5CC05164A |
[16] |
HE H, MENG S, LI H M, et al. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging[J]. Mikrochim Acta, 2021, 188(5):154. doi: 10.1007/s00604-021-04810-4 |
[17] |
COELHO S C, REIS D P, PEREIRA M C, et al. Doxorubicin and varlitinib delivery by functionalized gold nanoparticles against human pancreatic adenocarcinoma[J]. Pharmaceutics, 2019, 11(11):551. doi: 10.3390/pharmaceutics11110551 |